Literature DB >> 32552090

The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage.

Yu Gao1, Linlin Ma1, Fang Liang1, Yi Zhang1, Lin Yang1, Xuehua Liu1, Jing Yang1.   

Abstract

BACKGROUND: Amantadine is currently recommended for use in patients of post-traumatic brain injury with unresponsive wakefulness syndrome (UWS). However, the application of amantadine in UWS after cerebral hemorrhage has only been rarely reported. This allows for a further exploration of the role of amantadine in the treatment of UWS resulting from a severe cerebral hemorrhage.
METHODS: We observed the changes of seven patients with UWS of intracerebral hemorrhage after taking amantadine. We also carried out a detailed neurological examination of the patient with disorders of consciousness to include or exclude subjects for the study. CRS-R score was used to evaluate the neurological recovery.
RESULTS: An improvement in consciousness was observed within 3-6 days after the start of amantadine administration in all seven cases (n = 7/7; 100%). Five patients recovered conscious and left aphasia, hemiplegia and other sequelae, and two patients recovered from UWS to minimally conscious state (MCS).
CONCLUSIONS: In this study, amantadine administration showed substantial positive effects on recovery following severe cerebral hemorrhage. We recommend further randomized controlled studies to determine the efficacy of amantadine.

Entities:  

Keywords:  Amantadine; cerebral hemorrhage; unresponsive wakefulness syndrome

Mesh:

Substances:

Year:  2020        PMID: 32552090     DOI: 10.1080/02699052.2020.1780315

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  6 in total

Review 1.  Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.

Authors:  Rui-Zhe Zheng; Zeng-Xin Qi; Zhe Wang; Ze-Yu Xu; Xue-Hai Wu; Ying Mao
Journal:  Neurosci Bull       Date:  2022-07-08       Impact factor: 5.203

2.  Emerging Treatments for Disorders of Consciousness in Paediatric Age.

Authors:  Hassna Irzan; Marco Pozzi; Nino Chikhladze; Serghei Cebanu; Artashes Tadevosyan; Cornelia Calcii; Alexander Tsiskaridze; Andrew Melbourne; Sandra Strazzer; Marc Modat; Erika Molteni
Journal:  Brain Sci       Date:  2022-01-31

3.  Effect of Cinepazide Maleate on Serum Inflammatory Factors of ICU Patients with Severe Cerebral Hemorrhage after Surgery.

Authors:  Jing Zhang; Xia Zhang; Yun Shang; Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-28       Impact factor: 2.629

Review 4.  Role of the Dopaminergic System in the Striatum and Its Association With Functional Recovery or Rehabilitation After Brain Injury.

Authors:  Antonio Verduzco-Mendoza; Paul Carrillo-Mora; Alberto Avila-Luna; Arturo Gálvez-Rosas; Adriana Olmos-Hernández; Daniel Mota-Rojas; Antonio Bueno-Nava
Journal:  Front Neurosci       Date:  2021-06-24       Impact factor: 4.677

Review 5.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

Review 6.  Music Stimulation for People with Disorders of Consciousness: A Scoping Review.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Lorenzo Desideri
Journal:  Brain Sci       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.